These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 16778979

  • 1. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
    Li XG, Lu YM, Gu F, Yang XL.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun 18; 38(3):310-3. PubMed ID: 16778979
    [Abstract] [Full Text] [Related]

  • 2. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
    Menees SB, Powell C, Kurlander J, Goel A, Chey WD.
    Am J Gastroenterol; 2015 Mar 18; 110(3):444-54. PubMed ID: 25732419
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH, Chou JW, Chen SM, Tsai MC, Sun YS, Lin CC, Lin CP.
    Mol Med Rep; 2014 Jul 18; 10(1):522-6. PubMed ID: 24788223
    [Abstract] [Full Text] [Related]

  • 8. [Fecal calprotectin concentration in the differential diagnosis of bowel diseases].
    Osipenko MF, Livzan MA, Skalinskaya MI, Lyalyukova EA.
    Ter Arkh; 2015 Jul 18; 87(2):30-33. PubMed ID: 25864345
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):615-21. PubMed ID: 15352909
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
    David LE, Surdea-Blaga T, Dumitrascu DL.
    Sao Paulo Med J; 2015 Sep 15; 133(4):343-9. PubMed ID: 26039537
    [Abstract] [Full Text] [Related]

  • 12. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H, Desai D, Abraham P, Joshi A, Gupta T, Dherai A, Ashavaid T.
    Indian J Gastroenterol; 2015 Nov 15; 34(6):431-5. PubMed ID: 26589229
    [Abstract] [Full Text] [Related]

  • 13. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O, Ohem J, Mitrova K, Durilova M, Kotalova R, Nevoral J, Kolho KL, Bronsky J.
    Clin Lab; 2014 Nov 15; 60(12):1993-2000. PubMed ID: 25651733
    [Abstract] [Full Text] [Related]

  • 14. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC, Bachmann Holmetoft U, Ingdam Halkjær S, Angeliki Krogfelt K, Munk Petersen A.
    Scand J Gastroenterol; 2016 Nov 15; 51(2):211-7. PubMed ID: 26359672
    [Abstract] [Full Text] [Related]

  • 15. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
    Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, Pellicano R, Astegiano M, Bresso F.
    Scand J Gastroenterol; 2014 Dec 15; 49(12):1419-24. PubMed ID: 25369978
    [Abstract] [Full Text] [Related]

  • 16. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2005 Apr 15; 40(4):450-5. PubMed ID: 15795593
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C, David L, Portincasa P, Dumitraşcu DL.
    Rom J Intern Med; 2012 Apr 15; 50(1):3-6. PubMed ID: 22788087
    [Abstract] [Full Text] [Related]

  • 18. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec 15; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 19. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, Clar C, Johnston R.
    Health Technol Assess; 2013 Nov 15; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [Abstract] [Full Text] [Related]

  • 20. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.
    Dis Colon Rectum; 2007 Oct 15; 50(10):1697-706. PubMed ID: 17762964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.